Ocular manifestations of sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 23, Issue 6, 2002, Pages 543-548

  Bradley, Deborah ^a   Baughman, Robert P ^a   Raymond, Lawrence ^a   Kaufman, Adam H ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Iritis; Ocular manifestations; Pars planitis; Sarcoidosis; Scleritis; Uveitis; Vitritis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPLEGIC AGENT; METHOTREXATE; STEROID;

ARTICLE; CATARACT; CLINICAL TRIAL; DACRYOCYSTITIS; DISEASE COURSE; EYE DISEASE; EYE INFLAMMATION; EYE MOVEMENT DISORDER; EYE PAIN; GEOGRAPHY; GLAUCOMA; HISTOLOGY; HUMAN; INTERMEDIATE UVEITIS; IRITIS; KERATOCONJUNCTIVITIS SICCA; OPTIC NERVE DISEASE; PHOTOPHOBIA; PRIORITY JOURNAL; RACE; SARCOIDOSIS; SCLERITIS; UVEITIS; VISUAL IMPAIRMENT;

EID: 0036909580     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36518     Document Type: Article

References (34)

1. Hunter DG, Foster CS. Ocular manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1994:1217-1224
2. Izumi T. Symposium: Population differences in clinical features and prognosis of sarcoidosis throughout the world. Sarcoidosis 1992;9(suppl):S105-S118
3. Angi MR, De Caro G, Bergamo L, et al. Low prevalence of uveitis in Italian sarcoidosis patients. Sarcoidosis 1991;8:181-182
4. Stavrou P, Foster CS. Sarcoidosis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002:710-725
5. James DG. Ocular sarcoidosis. Ann N Y Acad Sci 1986;465:551-563
6. Raymond LA, Spaulding AG, Vilter RW. Peripheral retinal neovascularization in sarcoidosis with thalassemia. Ann Ophthalmol 978;10:745-748
7. Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol 1986;30:215-228
8. Rothova A. Ocular involvement in sarcoldosis. Br J Ophthalmol 2000;84:110-116
9. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985;107:689-693
10. Manouvrier-Hanu S, Puech B, Peitte F, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: A new family and review of the literature. Am J Med Gen 1998;76:217-221
11. Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 1996;59:1097-1107
12. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-852
13. Yamaguchi M, Hosada Y, Sasaki R. Epidemiological study on sarcoidosis in Japan: Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989;6:138
14. Rothova A, Alberts C, Glasius E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989;72:287-296
15. Samson CM, Waheed N, Baltatzis S, et al. Methotrexate therapy for chronic noninfectious uveitis. Ophthalmology 2001;108:1134-1139
16. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:60-66
17. Baughman RP. Methotrexate for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:147-149
18. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54:742-746
19. Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveltis. Ophthalmology 1999;106:111-118
20. Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846-1853
21. Baughman RP, Lower EE, Bradley DA, Kaufman AH. Use of cytotoxic therapy for chronic ophthalmic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(suppl):S17
22. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:133-137
23. Edelsten C, Pearson A, Joynes E, et al. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye 1999;13(pt 6):748-753
24. Kaye GB, Salmon JF, Isaacs S. Risk factors for uveitis in sarcoidosis. S Afr Med J 1993;83:342-344
25. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102:297-301
26. Martinetti M, Tinelli C, Kolek V, et al. "The Sarcoidosis Map": A joint survey of clincal and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564
27. Merritt JC, Whitsett CF, Daffin L, et al. HLA-A, -B, and -DR antigenic factors in ocular sarcoidosis. Am J Ophthalmol 1983;96:396-397
28. Baughman RP, Teirstein AS, Judson MA, et al and A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889
29. Rothova A, Suttorp-van Schulten MS, Frits TW, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-336
30. Dresner MS, Brecher R, Henkind P. Ophthalmology consultation in the diagnosis and treatment of sarcoidosis. Arch Intern Med 1986;146:301-304
31. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Am J Resp Crit Care Med 1999;160:736-755; Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173
32. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Am J Resp Crit Care Med 1999;160:736-755; Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173
33. Johns CJ, Michele TM. The clinical management of sarcoidosis: A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999;78:65-111
34. Obenauf CD, Shaw HE, Sydnor CF, et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978;86:648-655